Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03331263 · ClinicalTrials.gov registry record · Phase 1
Single Dose CHG Pharmacokinetic Study
A Phase 1 study, sponsored by Medline Industries.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT03331263 is a Phase 1 study that has completed, run by Medline Industries. The registered enrollment target is 12 participants.
The verdict
NCT03331263, a Phase 1 study, has completed, sponsored by Medline Industries.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
A single 2% topical application of ReadyPrep® CHG was applied on either the abdomen (Treatment-1) or the groin (Treatment-2) whereas Treatment-3 consisted of a control treatment where the same procedure as Treatment-1 and -2 was performed, but without the topical application of ReadyPrep® CHG. The treatments were separated by a wash-out of 7 calendar days.
Interventions
- DRUG Chlorhexidine Gluconate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-07-21 |
| Est. Completion | 2017-08-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03331263
The ClinicalTrials.gov registry entry for NCT03331263 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medline Industries, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Chlorhexidine Gluconate is the first listed.
NCT03331263 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03331263 about?
NCT03331263 is a clinical study titled "Single Dose CHG Pharmacokinetic Study". A single 2% topical application of ReadyPrep® CHG was applied on either the abdomen (Treatment-1) or the groin (Treatment-2) whereas Treatment-3 consisted of a control treatment where the same procedure as Treatment-1 and -2 was performed, but without the topical application of ReadyPrep® CHG. The t...
What is the current status of trial NCT03331263?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2017-07-21. Estimated completion is 2017-08-06.
What interventions are being tested in trial NCT03331263?
The interventions under investigation include: Chlorhexidine Gluconate (DRUG).
Who is sponsoring clinical trial NCT03331263?
This trial is sponsored by Medline Industries, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.